Iontophoretic Administration of Prostaglandin E1 in Peripheral Arterial Occlusive Disease

Annals of Pharmacotherapy

Volumn 37, Issue 5, 2003, Pages 747-

  Sakurai, Tsunehisa ^a   Yamamura, Keiko ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; INSULIN; PROSTAGLANDIN E1; TICLOPIDINE;

ADULT; CASE REPORT; DIABETES MELLITUS; DRUG DELIVERY SYSTEM; HUMAN; HYPERTENSION; IONTOPHORESIS; LETTER; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; THROMBOEMBOLISM; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

AGED; ALPROSTADIL; ARTERIAL OCCLUSIVE DISEASES; HUMANS; IONTOPHORESIS; MALE; SKIN; SKIN ULCER; VASODILATOR AGENTS;

EID: 0242499873     PISSN: 10600280     EISSN: 15426270     Source Type: Journal    
DOI: 10.1345/aph.1C367     Document Type: Letter

References (4)

1. Pentecost MJ, Criqui MKH, Dorros G, Goldstone J, Johnston KW, Martin EC, et al. Guidelines for peripheral percutaneous transluminal angioplasty of the abdominal aorta and lower extremity vessels. Circulation 1994; 89: 511–31.
2. William R. Medical treatment of peripheral arterial disease and claudication. N Engl J Med 2001; 344: 1608–21.
3. Golub M, Zia P, Matsuno M, Horton R. Metabolism of prostaglandins A1 and E1 in man. J Clin Invest 1975; 56: 1404–10.
4. Saeki S, Yamamura K, Matsushita M, Nishikimi N, Sakurai T, Yuji N. Iontophoretic application of prostaglandin E1 for improvement in peripheral microcirculation. Int J Clin Pharmacol Ther 1998; 36: 525–9.